Beijing Jinhao Pharmaceutical Real-time Fluorescent Quantitative PCR Analyzer Obtained Class III Medical Device Registration Certificate
Release time：2022.10.25
Beijing Jinhao Pharmaceutical Co., Ltd. (referred to as "Jinhao Pharmaceutical")'s real-time fluorescent quantitative PCR analyzer has been awarded the Class III medical device product registration certificate by the National Medical Products Administration (NMPA) (Registration No. 20223221369). Four years of hard work have finally borne fruit!
In recent years, influenced by the COVID-19 pandemic, molecular diagnostic technologies represented by nucleic acid testing have rapidly become widespread. The real-time fluorescent quantitative PCR analyzer certified this time by Jinhao Pharmaceutical, as part of the company's PCR product series solution platform, integrates a high-quality temperature control module and a high-performance optical system, featuring fast detection speed, high automation, and ease of operation. Additionally, this product is available in multiple models to meet the application needs of qPCR in different scenarios, supporting the application and development of molecular diagnostic technology in clinical testing, scientific research services, and more.
Copyright © 2025 Beijing Kinghawk Pharmaceutical Co., Ltd. All rights reserved.